Nikolai Bespalov
Nikolai Bespalov is a director of development at RNC Pharma, an analytical company specializing in the pharmaceutical market. He is known for providing insights into the supply and demand of essential medications, particularly in relation to the current challenges facing the availability of carbamazepine and its derivatives in Russia.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Russia | 2 | 6.00 | 0.15% | +0% | 144,104,080 | 221,358 | $1,500,000 | 2,304$ |
| Totals | 2 | 144,104,080 | 221,358 | $1,500,000 | 2,304$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Russia:
Nikolai Bespalov is the director of development at an analytical company who estimated the daily revenue of pharmacy networks.
5
Russia:
Nikolai Bespalov noted that the revenue figures provided by 'Kontur.Fokus' include the entire volume of the company's business.
7
Russia:
Nikolai Bespalov is the director of development at RNC Pharma who noted the growth in pharmacy sales.
7
Russia:
Nikolai Bespalov, the director of the analytical company RNC Pharma, commented on the market situation regarding the drug.
5
Russia:
Nikolai Bespalov, the director of the analytical company RNC Pharma, commented on the market situation regarding the drug.
5
Russia:
Nikolai Bespalov, the director of the analytical company RNC Pharma, commented on the market situation regarding the drug.
5
Russia:
Nikolai Bespalov, the director of the analytical company RNC Pharma, commented on the market situation regarding the drug.
5
Russia:
Nikolai Bespalov is the development director of the analytical company RNC Pharma.
5
Russia:
Nikolai Bespalov, the director of the analytical company RNC Pharma, commented on the market situation regarding the drug.
5